Analysis of Clinical Prognostic Variables for Triple Negative Breast Cancer Histological Grading and Lymph Node Metastasis by Cernea, Ana et al.
 Freely Available  Online 
www.openaccesspub.org   JMID      CC-license         DOI : 10.14302/issn.2641-5526.jmid-18-2488             Vol-1 Issue 1 Pg. no.–  14  
 JOURNAL OF MEDICAL INFORMATICS AND DECISION MAKING  
ISSN NO: 2641-5526  
Research Article 
Analysis of Clinical Prognostic Variables for Triple Negative Breast Cancer Histological Grading and 
Lymph Node Metastasis 
1Group of Inverse Problems, Optimization and Machine Learning. Department of Mathematics, Universidad de 
Oviedo, Oviedo, Asturias, Spain 
2Department of Informatics, Universidad de Oviedo, Oviedo, Asturias, Spain 
3Institut für Pathologie. University of Bern, Switzerland 
Servicio de Anatomía Patologica, Hospital Universitario de Asturias
Abstract 
Background: Triple Negative Breast Cancer (TNBC) is a type of breast cancer with very bad prognosis. 
Predicting the histological grade (HG) and the lymph nodes metastasis is crucial for developing more suitable 
treatment strategies.  
Methods: We present the main clinical and pathological variables to predict the histological grade and lymph 
nodes metastasis via novel machine learning techniques. These variables are currently being used for prognosis 
and treatment in medical practice. This analysis was performed using a database of 102 Caucasian women 
diagnosed with TNBC. The results were cross-validated using random simulations of this dataset.  
Results: HG was predicted with an accuracy of 93.8% using a list of 6 prognostic variables with significant 
implications: Ki67 expression, use of Oral contraceptives, Col11A1 expression, Col11A1 score, E-cad truncated 
and Tumor size. The lymph nodes metastasis was predicted with an accuracy of almost 85% using only 6 
prognostic variables: Vascular invasion, Tumor size, Perineural invasion, Age at diagnosis, Ki67 expression, and 
Col11A1 score. This analysis also served to establish the median signatures of the groups with and without 
lymph node metastasis, and proved the existence of a kind of small-size tumors (around 2.15 cm) with lymph 
node metastasis but not showing vascular and perineural invasions and higher protein Col11A1 score. Besides, 
these signatures proved to be very stable.  
Conclusions: The additional information conveyed by the prognostic variables found in these two classification 
problems provides new insight about the genesis and progression of this disease and can be used in medical 
practice to improve decisions in patient diagnosis and further treatment. 
DOI : 10.14302/issn.2641-5526.jmid-18-2488  
Corresponding Author: c/ Federico    
García Lorca 18, Oviedo, Asturias, Spain, Tel: +34 985103199, E mail: jlfm@uniovi.es  
Keywords: Lymph Nodes, Machine Learning, Triple Negative Breast Neoplasms, Tumor Grading. 
Received: Nov 21, 2018                      Accepted: Dec 04, 2018             Published: Dec 13, 2018 
Editor: Yu-Dong Zhang, University of Leicester, United Kingdom. 
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
54
51
 
| 
do
wn
lo
ad
ed
: 
4.
12
.2
01
9
 Freely Available  Online 
www.openaccesspub.org   JMID      CC-license         DOI : 10.14302/issn.2641-5526.jmid-18-2488             Vol-1 Issue 1 Pg. no.–  15  
Background 
 Breast cancer is a very heterogeneous disease. 
This term includes a variety of entities with distinct 
morphological features and clinical behaviors. For a long 
time, breast tumors have been classified according to 
their morphological features (histological type and 
grade) to ascertain prognostic outcome in patients. 
Subsequently, molecular markers were used to provide 
additional predictive power. 
 Triple Negative Breast Cancers (TNBC) refers to 
any breast cancer characterized by the absence of 
Estrogen Receptors (ER), Progesterone Receptors (PR) 
and Human Epidermal Growth factor 2 receptors 
(HER2). A correct classification of TNBC samples is 
important from a clinical and therapeutic point of view 
for deciding treatment strategies, since TNBC are 
resistant to targeted therapies [1, 2]. Besides, statistical 
analyses have shown that TNBC accounts for              
approximately  15%-25%of all breast cancers [3]. 
Recently, a molecular classification of tumors based on 
gene expression profiles was proposed [4] and served to 
define five different subtypes of breast cancer that were 
not previously detected using traditional                            
histo-pathological methods [5]. This classification 
includes the basal-like tumors group which are defined 
by one of the following conditions [6]: (1) the lack of 
ER, PR, and HER2 expression; (2) the expression of one 
or more high-molecular-weight/basal cytokeratins 
(CK5/6, CK14); (3) the lack of expression of ER and 
HER2, in conjunction with the expression of CK5/6; and 
(4) the lack of expression of ER, PR, and HER2 in 
conjunction with the expression of CK5/6. Among these 
four cases two match with definition of TNBC.  Also, 
from a morphological point of view basal-like and triple 
negative breast cancers share a predominance of high 
histological grades. The analysis of gene expression 
profiles showed a 77% overlap between TNBC and the 
intrinsic basal-like subtype, but TNBC also includes       
some special histological types such as medullary and 
adenoidcystic carcinoma with low risks of distant 
recurrence [2, 4, 7, 8]. 
 The treatment options for TNBC are adjuvant 
chemotherapy and radiotherapy. Unfortunately, 
response to chemotherapy does not correlate with 
overall survival. In addition, recurrences are observed in 
TNBC during the first and third years after treatment, 
and most deaths take place in the first five years. The 
survival decreases after the first distant metastatic event 
[9]. Therefore, in this heterogeneous group of tumors, 
new identification and classification techniques are 
necessary to better predict diagnosis and prognosis in 
order to establish appropriate therapies and improve 
patient survival [10].   
 The histological grade (HG) of the TNBC 
samples is used to decide the treatment, and it is 
commonly established according to the Nottingham 
Histological Score system (the Elston-Ellis modification of 
Scarff-Bloom-Richardson grading system) [11-13]. This 
system is based on the ability of the tumor to form 
structures similar to the ducts where the tumor is 
originated, on the similarity between the cancer cells 
and the original benign cells, and finally on their 
proliferating activity. The cells and tissue structure of 
breast cancer are histopathologically examined to 
determine how aggressive the cancer is. Lower grade 
tumors with a better prognosis can be treated less 
aggressively and have a better survival rate. Higher 
grade tumors are treated more aggressively causing 
adverse effects due to more aggressive medications. 
Therefore, the histological grade assignment plays 
important role in deciding treatment options of TNBC 
and also in prognosis. The main variables involved in 
this grading system are Mitotic count, Nuclear 
Pleomorphism, and Tubule Formation. The Mitotic count 
score depends on the field diameter of the microscope 
used by the pathologist. In the present case, it was 
established by counting how many mitotic figures are 
seen in 10 high power fields [14, 15]. The Nuclear 
Pleomorphism score increases with the variation of size 
and shape of cells, from small nuclei to larger cells with 
vesicular nuclei [16]. Finally, the Tubule formation 
decreases with the percentage of tumor area forming 
glandular/tubular structures [17]. 
 The aim of this research is to provide the main 
pathological and immuno-histochemical variables that 
have the greatest predictive accuracy for the most 
aggressive TNBC histological grades 2 and 3 (named 
HG2 and HG3) and of lymph nodes metastasis. For that 
we have used a cohort of 102 Caucasian women 
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diagnosed at Hospital Universitario Central de Asturias 
(Spain) with TNBC, 96 of them with prescribed 
histological grade, and 72 of them controlled for lymph 
nodes metastasis.  
 The methodology used in this paper is based on 
machine learning techniques and have been successfully 
previously applied in the prediction of treatment 
response in Hodgkin Lymphoma [18] and in addressing 
different Chronic Lymphocytic Leukemia decision-making 
problems [19] using clinical data. In the present case, 
the histological grade was predicted with a                 
leave-out-one-cross-validation (LOOCV) accuracy of 
almost 64 and the lymph node metastasis with that of 
84%. Besides, we provide analysis of the confusion 
matrix corresponding to the optimum classifier and 
different associations of prognostic variables with high 
predictive accuracy that serve to appraise the       
uncertainty of the corresponding prediction                  
problems and to better understand the genesis of this 
disease [20, 21]. 
Methods 
 The methodology presented here aims at 
assessing the histological grade of new TNBC incoming 
samples and understanding the main prognostic 
variables involved in lymph nodes metastasis. The aim of 
this analysis is also to provide clinicians with expert 
systems to assist medical decisions. 
Dataset Description 
 A cohort of 102 Caucasian women diagnosed in 
Hospital Universitario Central de Asturias (Oviedo, 
Spain), with TNBC and ages between 30 and 94 years 
were enrolled in this study, which was developed in 
accordance with the Helsinki Declaration of 1975. This 
study was approved by the ethics committee (IRB 
approval 193/17) with the patient informed consent. 
Tumor samples were obtained from surgical resection. 
Samples were fixed in 10% formaldehyde and paraffin 
embedded, then cut 4μm thick, mounted on treated 
slides, and stained with Hematoxylin and Eosin (H&E) 
stain. Finally, these sections were studied and 
photographed at two different resolutions (100X and 
400X) using an Olympus light microscope. Most of the 
cancers in this cohort were classified as histological 
grades 2 and 3. The clinical and pathological                    
characteristics of the cohort are provided in the 
supplementary material (Tables 1 and 2). The survival 
time in this cohort has a median of 40 weeks and lower 
and upper quartiles of 25 and 61 weeks respectively. 
 The TNBC samples are categorized into HG2 
when the total score falls between 6 and 7 points and 
HG3 when it falls between 8 and 9. In our database, 
75% of the samples belong to the HG3 group (see                  
table 2). Besides, other variables used by the 
pathologists are the TNM stage that takes into 
consideration the Tumor size (T) and the presence of 
any lymph Nodes metastases (N) or distant organ 
Metastases (M); the Vascular and Perineural invasion 
that indicates the presence or absence of tumor cells 
inside the vessels and nerves, the Nipple and/or skin 
invasion, and also the Necrosis. The tumor size in our 
cohort varies between 0.1 and 6.5cm with a median size 
of 2 cm. Different immuno-histochemical variables were 
also monitored due to its importance in predicting TNBC 
prognosis and treatment response [22-29]: the hormone 
receptor status (ER, PR and Androgen Receptor-AR); 
HER2, Ki67, Bcl2, p53, CK5/6, CK14 and Col11A1 
expressions.  
 Table 3 shows the list of all the clinical variables 
used in this study, together with their sampling 
frequency. It can be observed that all                          
immuno-histochemical variables are sampled in100% of 
the samples. Variables with sample frequencies lower 
than 100 are imputed. Perineural invasion was the only 
pathological variable that needed to be imputed 
(sampled in 98% of the samples). In the case of clinical 
characteristics, Menopause is the only variable that has 
been determined on all samples. On the other hand, the 
Histological Grade (HG) and the lymph Nodes metastasis 
(N) will be used for the class assignment in the                  
two-different machine learning classification problems 
that are analyzed in this paper.  
Machine Learning Methodology 
 The machine learning methodology used in this 
paper is described in figure 1. The first step consists in 
pre-processing the database and reading the different 
clinical variables of the samples that are involved in the 
class assignment for the different classification problems 
(histological grade and lymph nodes metastasis). 
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Variable  Category Number  Percentage (%) 
Age 
(Mean = 59, Min=30, Max = 94) 
≤59 54 52.90 
>59 48 47.10 
Tumor size 
≤ 2.1 57 55.88 
>2.1 45 44.12 
Histological grade 
Grade 1 2 1.96 
Grade 2 19 18.63 
Grade 3 75 73.53 
Unknown 6 5.88 
N 
 Negative nodes 45 44.12 
Positive nodes 26 25.49 
Unknown 31 30.39 
Vascular invasion 
Negative 80 78.43 
Positive 22 21.57 
Perineural invasion 
Negative 91 89.22 
Positive 11 10.78 
Lactation 
Non lactation 16 15.70 
Lactation 45 44.10 
Unknown 41 40.20 
Pregnancies 
Non pregnancies 17 16.70 
Pregnancies 71 69.60 
Unknown 14 13.70 
Family History BOE 
(Breast, Ovary and Endometrial cancer) 
without B, O, E (0) 38 37.30 
with B, O, E (1) 34 33.30 
Unknown 30 29.40 
Family History Cancer 
without cancer (0) 20 19.60 
with cancer (1) 58 56.90 
Unknown 24 23.50 
Oral contraceptives 
Non oral contraceptives (0) 29 28.40 
Oral contraceptives (1) 27 26.50 
Unknown 46 45.10 
Alcohol consumption 
Non drinker (0) 65 63.70 
Drinker (1) 12 11.80 
Unknown 25 24.50 
Tobacco consumption 
Non smoker (0) 46 45.10 
Smoker (1) 32 31.40 
Unknown 24 23.50 
Table 1. Clinic-pathological characteristics of 102 analyzed patients with TNBC. Binary values coded as            
follows: Negative=0, Positive=1. Unknown values are interpolated. 
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Variable Cathegory Number of samples  Percentage (%) 
Tubule formation >75% of tumor 73 71.57 
  10-75% of tumor 20 19.61 
  < 10%of tumor 3 2.94 
  unknown 6 5.88 
Nuclear Pleomorfism moderate variation in size and shape 6 5.88 
  marked variation 90 88.24 
  unknown 6 5.88 
Mitotic count 0-8 mitotic counts 13 12.75 
  8-16 mitotic counts 17 16.67 
  over 16 mitotic counts 66 64.71 
  unknown 6 5.88 
AR expression Negative 72 70.59 
  Positive 30 29.41 
Ki67 expression <20% 11 10.78 
  20-50% 31 30.39 
  >50% 60 58.82 
P53 expression Negative 29 28.43 
  Positive 73 71.57 
Bcl2 expression Negative 50 49.02 
  Weak 33 32.35 
  Strong 19 18.63 
E-cadherin truncated in 
membrane 
Non-truncated 68 66.67 
Truncated 34 33.33 
Ck5/6 expression Negative 37 36.27 
  Focal 35 34.31 
  Diffuse 30 29.41 
Ck14 expression Negative 56 54.90 
  Focal 29 28.43 
  Diffuse 17 16.67 
Pro-Col11A1 expression 
Low (<=1) 54 52.94 
High (>1) 48 47.06 
Table 2. Pathological and immunohistochemical variables in the cohort of 102 women with TNBC. 
 Freely Available  Online 
www.openaccesspub.org   JMID      CC-license         DOI : 10.14302/issn.2641-5526.jmid-18-2488             Vol-1 Issue 1 Pg. no.–  19  
Type Variable Name Freq. (%) 
Pathological Variables Histological Grading (HG) 95.0 
  Mitotic Count (MC) 95.0 
  N 70.0 
  Necrosis (Necr) 100.0 
  Nuclear Pleomorphism (NP) 95.0 
  Perineural Invasion (PI) 98.0 
  Tubular Formation (TF) 95.0 
  Tumor Size (TS) 100.0 
  Vascular invasion (VI) 100.0 
Immunohistochemical  Variables AR expression (AR) 100.0 
  Bcl2 expression (Bcl2) 100.0 
  CK14 expression (ck14) 100.0 
  CK5/6 expression (ck5/6) 100.0 
  Col11A1 expression (ColE) 100.0 
  Col11A1 intensity (ColI) 100.0 
  Col11A1 score (ColS) 100.0 
  ER expression (ER) 100.0 
  HER2 expression (HER2) 100.0 
  Ki67 expression (Ki67) 100.0 
  p53 expression (p53) 100.0 
  PR expression (PR) 100.0 
Clinical Characteristic Age at diagnosis 100.0 
  Age at Menarche 79.4 
  Age First Child 35.3 
  Lactation 59.8 
  Pregnancies 86.3 
  Familiar History BOE 70.6 
  Family History Cancer 76.5 
  Oral contraceptives 54.9 
  Alcohol consumption 75.5 
  Tobacco consumption 76.5 
  Menopause 100.0 
Table 3. Clinical variables used in this analysis, and their sampling frequency. 
Samp. freq.= sampling frequency 
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FR= Fisher’s ratio 
Table 4. Histological grade (HG) prediction: ranked list of prognostic variables according to their Fisher 
ratio. C1 and C2 stand for the two classes of histological grades, HG2 and HG3, respectively. Bold faces 
show the maximum mean values of the variables in each group. 
Variable 
Mean 
HG2 
Std 
HG2 
Mean 
HG3 
Std 
HG3 
FR 
Accuracy 
(%) 
Ki67 expression 1.67 0.80 2.71 0.46 1.28 72.9 
AR expression 0.76 0.44 0.17 0.38 1.03 81.2 
Oral contraceptives 0.00 0.00 0.33 0.47 0.50 85.4 
Bcl2 expression 0.29 0.64 0.80 0.77 0.26 84.4 
CK14 expression 0.24 0.54 0.72 0.78 0.26 82.3 
Col11A1 score 1.33 1.71 2.73 2.50 0.21 84.4 
Col11A1 intensity 0.67 0.73 1.16 0.84 0.20 84.4 
E-cad truncated 0.14 0.36 0.41 0.50 0.20 90.6 
Age at diagnosis 66.57 13.80 57.69 14.64 0.19 79.2 
Tumor Size 1.65 0.92 2.32 1.34 0.17 81.3 
Col11A1 expression 1.00 1.10 1.56 1.21 0.12 80.2 
Lactation 0.95 0.22 0.80 0.40 0.11 79.2 
Necrosis 1.00 0.84 1.37 0.78 0.11 80.2 
Pregnancies 2.29 1.42 1.71 1.10 0.10 78.1 
Tobacco Smoking 0.19 0.40 0.36 0.48 0.07 78.1 
Perineural invasion 0.05 0.22 0.13 0.34 0.04 78.1 
Age at Menarche 12.90 1.26 12.53 1.47 0.04 76.0 
Vascular invasion 0.14 0.36 0.23 0.42 0.02 77.1 
Family History (BOE) 0.71 0.46 0.61 0.49 0.02 78.1 
CK5/6 expression 0.81 0.75 0.95 0.82 0.01 79.2 
N 0.24 0.44 0.31 0.49 0.01 77.1 
Alcohol consumption 0.10 0.30 0.12 0.33 <0.01 77.1 
Age First Child 25.10 3.11 24.95 3.39 <0.01 76.0 
Menopause 0.95 0.22 0.95 0.23 <0.01 76.0 
p53 expression 0.71 0.46 0.72 0.45 <0.01 77.0 
Family History (Cancer) 0.81 0.40 0.81 0.39 <0.01 75.0 
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Figure 1. Flow chart of the novel machine learning 
methodology used in this paper. 
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Samples with missing values are imputed using a 
nearest-neighbor interpolation algorithm [18, 19]. 
 The discriminatory power of the different 
variables is established according to their Fisher’s Ratio 
(FR).  In a binary classification, the Fisher’s ratio of the 
attriute  j is defined as: 
 
 
where  μji is a measure of the center of mass of the 
probability distribution of the attribute j in class i, and              
σji is a measure of its dispersion within this class. 
Discriminatory attributes correspond to higher Fisher’s 
ratios since they have a low intra-class dispersion                
(intra-class homogeneity) and high inter-class distance 
that accounts for the separation between the centers of 
the corresponding prognostic variable distributions. 
 The algorithm used for prediction and finding 
the minimum-size list of prognostic variables is 
composed of 4 steps.  
•  The first one is the variable ranking and 
selection. Attributes are ranked decreasingly 
according to their Fisher’s ratio values. The attribute 
with the highest score is the main prognostic 
variable for the class discrimination. The algorithm 
finds the minimum size list of prognostic variables 
with the optimum accuracy by adding iteratively 
attributes with smaller Fisher’s ratios in order to 
span high frequency details of the class discrimina-
tion [30-32]. The set with the optimum accuracy 
and minimum size is therefore selected. The 
accuracy of the different lists is based on Leave-One
-Out Cross-Validation (LOOCV) via a simple distance-
based classifier built with the reduced set of 
discriminatory variables [18, 19]. LOOCV is a                    
well-established method in which a single sample 
from the original dataset serves as the validation 
data (sample test), and the remaining samples as 
training data. The class assignment is based on a 
nearest-neighbor classifier in the reduced base, that 
is, the class with the minimum distance in the 
reduced base to the sample test is assigned to the 
sample test. The average LOOCV predictive accuracy 
is calculated by iterating over all the samples. This 
algorithm serves to find the Small-Scale Signature 
with the highest LOOCV predictive accuracy, which 
provides an estimation of the predictive accuracy of 
new incoming samples.   
•  The second step is the Random sampling of 
prognostic networks to find other different networks 
of highly discriminatory prognostic variables. The 
existence of these networks has been explored in 
[20, 21]. The prior sampling probability of a 
prognostic variable is considered to be proportional 
to its Fisher’s ratio. That way the most discriminato-
ry variables are preferentially sampled. After the 
sampling has been accomplished, the most 
discriminatory networks are determined, and the 
posterior sampling frequencies of the main 
prognostic variables involved in these networks are 
analyzed.  
•  The third step is the Stability and ROC Analysis. 
The stability of these signatures is also examined by 
random 75/25 (75% of samples used for training 
and 25% for validation) hold-out experiments. The 
aim of the hold-out procedure is two-fold checking 
the stability of the predictive accuracy of the small-
scales signatures found via LOOCV when the 
number of training samples is decreased. In this 
case, the minimum-scale signature is read in the 
training data set for building the nearest-neighbor 
classifier and it is applied to establish the small-scale 
signature predictive accuracy in the validation set. 
The cumulative distribution function of the small-
scale predictive accuracies found in different hold-
outs is finally presented and serves to account for 
the variability in its predictive accuracy with partial 
information. A statistical analysis is performed 
providing theinter-quartile, standard deviation, mean 
and median bounds that could be expected in an 
independent dataset. These cross-validation 
techniques serve to take into account the effect of 
the limited size of the biomedical datasets used for 
training and validation, in order to predict how these 
signatures would generalize for new incoming 
samples, since in real problems it is very difficult to 
find a database with a similar design, to perform an 
independent validation of the results. In the ROC 
analysis (see for instance Park et al, 2004) [33]. We 
provide various metrics of the diagnostic ability of 
the most predictive signatures derived from the 
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confusion matrix: sensitivity (true positive rate or 
the probability of detection) and specificity (true 
negative rate). Finally, the correlation network is 
built using the minimum spanning tree via Kruskal’s 
algorithm [34] and the Pearson Correlation 
coefficient among the most discriminatory variables. 
The weights of this connected graph are the 
correlation coefficients between the corresponding 
prognostic variables. The head of the tree is the 
most discriminatory variable of the corresponding 
classification problem, whereas the branches contain 
the variables that are weakly correlated to the 
headers. The analysis of the correlation networks 
between prognostic variables might be of help for 
the physicians to understand the genesis of the 
disease. 
 The implicit idea behind this algorithm is that 
the classification problem becomes linearly separable 
when the most discriminatory prognostic variables are 
selected [35, 37]. This is a powerful idea based on the 
principle of parsimony, which should be used in all 
disciplines. Besides, when these accuracies are low, 
other nonlinear classification algorithms (black-box 
models) should be used instead. If despite all these 
trials, no improvement in the accuracy is observed, then 
the data set (data and class) is noisy or that the 
variables do not convey enough information to answer 
the proposed question [20, 21]. 
Results 
Histological Grade Prediction 
 The aim of this analysis is to establish the 
discriminatory power of the immuno-histochemical, 
pathological and clinical variables for HG prediction. For 
that purpose, we did not use any of the three pathologi-
cal variables involved in the Scarff-Bloom-Richardson 
definition: Mitotic count, Nuclear pleomorphism and 
Tubule formation. This analysis established the optimum 
variables networks for the HG prediction, and showed 
how the clinical and pathological variables influence the 
disease development, particularly the patients’ daily 
habits (oral contraceptives intake, tobacco smoking (or 
tobacco consumption) and alcohol consumption). We 
had at disposal the histological grade of 96 TNBC 
samples: 21 samples in HG2 and 75 samples in HG3. 
 The variables used in this classification problem 
are presented in Table 4, ranked by their discriminatory 
power given by their Fisher’s ratios in decreasing order. 
The maximum Fisher’s ratio (FR) is 1.28 and             
corresponds to Ki67 expression, followed by AR 
expression with a Fisher’s ratio of 1.03, and Oral 
contraceptives with 0.50.  The rest of the variables have 
a lower FR and can only expand high frequency details 
of the classification problem [37]. In this case, using the 
most discriminatory variable (Ki67 expression) we have 
obtained a LOCCV predictive accuracy of 72.9%. The 
accuracy has increased to 81.3by adding the second 
discriminatory variable (AR expression), and up to 
85.4% by adding Oral contraceptives. The maximum 
accuracy (90.6%) is obtained using the list containing 
the8 first prognostic variables, which is the                  
minimum-size list in this case. This table also shows 
their mean and standard deviation within each class 
(HG2 and HG3) and the LOOCV predictive accuracies of 
the corresponding ranked lists of prognostic variables, as 
explained in the machine learning algorithm description, 
and the minimum-size signature with the highest 
predictive accuracy. Fisher’s ratio can be interpreted as 
a prior discriminatory power of the variables considered 
individually, while the LOOCV accuracy is the posterior 
discriminatory power of these variables working in 
synergy.  
 Table 5 shows the optimum classifier found by 
the random sampler with an accuracy of 93.8% using a 
list of only 6 prognostic variables: Ki67 expression, Oral 
contraceptives, Col11A1 score, E-cad truncated, Tumor 
Size, and Col11A1 expression and other networks of 
high discriminatory prognostic variables with a LOOCV 
predictive accuracy higher than 92%, together with their 
corresponding stability analysis and ROC analysis. 
Besides, these high predictive classifiers are very stable, 
with median accuracies of 91.7% and mean accuracies 
slightly lower, a low inter-quartile range (8.3) and the 
standard deviation (5.5) of the predictive accuracy.               
Subsequently, the ROC analysis shows a very high 
sensitivity (97%) and specificity (76%).  
 Besides, we provide a simple linear regression 
formula to perform a fast and useful estimation of the 
histological grading: 
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 Accuracy 93.8 %                   Accuracy 92.7 % 
Ki67 expression Ki67 expression Ki67 expression 
Oral contraceptives Oral contraceptives Oral contraceptives 
Col11A1 score Age at diagnosis E-cad truncated 
E-cad truncated Tumor Size Tumor Size 
Tumor Size Perineural Inv. Col11A1 expression 
Col11A1 expression p53 expression  
Classifier's stability (%) 
Median 91.7 91.7 91.7 
Mean 91.6 90.2 89.7 
IQR 8.3 8.3 4.2 
Std 5.5 5.7 5.6 
  ROC analysis (%) 
Sensitivity 97 96 96 
Specificity 76 81 76 
Table 5. HG prediction. Other high discriminatory networks with LOOCV predictive accuracies higher 
than 92% with their corresponding stability and ROC analysis. 
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 This regression formula has a low RMS error of 
0.2, that is, estimated histological grades lower than 2.3  
belong almost surely to HG2. This method complements 
the HG assessment provided by the Nottingham grading 
system in appraising this important decision problem 
concerning the patient treatment and prognosis.  
 Table 6 shows the main statistical results 
(median, mean, interquartile range, and standard 
deviation) of each predictive variables of the optimum 
classifier, calculated in the different groups of the 
confusion matrix (TP, TN, FP, and FN). The confusion 
matrix corresponding to the optimum classifier is     
 
 
 The samples of the TP group (HG3 correctly 
predicted) compared to the TN group (HG2 correctly 
predicted), present higher median Ki67 expression (3.0 
vs 1.0), higher Col11A1 score and Col11A1 expression 
(2.0 vs 0.5) and higher tumor size (2.10 vs 1.50). 
Besides, all the samples with null Oral contraceptives 
intake fall in the TN group. On the other hand, the main 
differences between FP (samples with HG3 incorrectly 
assigned to HG2 class) and TP are: lower values of Ki67 
(2.0 vs 3.0), no contraceptive intake for FP, lower 
ColA11 score and expression (1 vs 2) and Tumor size 
(1.0 vs 2.10).  Finally, the comparison between TN and 
FN (samples in HG3 incorrectly predicted) shows higher 
Ki67 expression (1 vs 2.5), higher expression of the 
ColA11 protein (0.50 vs 1.5), and much higher tumor 
size in the FN group (1.50 cm vs 3.35 cm).  
 Figure 2 shows the correlation network for the 
HG prediction problem and serves to provide the 
relationships between the most discriminatory variables.  
Lymph Nodes Metastasis Prediction 
 This classification problem tries to predict the 
presence or absence of lymph nodes metastasis, without 
making use of the HG variable, nor any of the 
pathological variables involved in the Nottingham score, 
and unraveling other prognostic variables at disposal 
that could be linked to this important problem in TNBC 
prognosis. In this case, we have at disposal 72 samples 
where 27 of them had one or two lymph nodes. Table 7 
shows the information concerning the ranked lists of 
prognostic variables used in the lymph nodes metastasis 
prediction problem. The maximum Fisher’s ratio in the 
Lymph Nodes Metastasis prediction is 0.45 and 
corresponds to Vascular invasion, followed by Tumor 
Size (0.19), and Perineural invasion (0.14), meanwhile 
the rest of variables show a very low FR (close to zero). 
Due to these low Fisher’s ratios, it is expected that this 
classification problem will be harder in terms of 
achieving a high predictive accuracy. The maximum 
accuracy (75%) is provided by the Vascular invasion 
alone. Then, the LOOCV accuracy drops to 73.61% 
considering the list of the first seven most discriminatory 
variables: Vascular invasion, Tumor Size, Perineural 
invasion, Age First Child, CK14 expression, CK5/6 
expression, and E-cad expression. This accuracy remains 
the same when we also add to the list the Family 
history.  
 Table 8 presents the optimum classifier found by 
the random sampler with an accuracy of 84.72% using a 
list of seven variables: Vascular invasion, Tumor Size, 
Perineural invasion, Family history, Age at diagnosis, 
Ki67 expression, and Col11A1 score. We also present 
and other networks of high discriminatory prognostic 
variables with a LOOCV predictive accuracy higher than 
83%. Their stability analysis shows that the median 
accuracies vary from 78% to 83.3%, the mean 
accuracies from 79% to 81.7%, the inter-quartile range 
from 5.5% to 11% and the standard deviation is around 
5 to 8%. In addition, the ROC rates prove a good ability 
of diagnostic of all the classifiers with sensitivities 
between 78% and 81% and specificities between 84% 
and 89%.  
 Table 9 shows the median, mean, interquartile 
range (IQR) and the standard deviation of the predictive 
variables of the optimum classifier in the different 
groups of the confusion matrix. The confusion matrix of 
the optimum classifier is:  
 
 
, 
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Variable  MeanC1  StdC1  MeanC2  StdC2  FR Accuracy 
Vascular invasion 0.48 0.51 0.09 0.29 0.45 75.0 
Tumor Size 2.74 1.30 1.92 1.36 0.19 66.7 
Perineural invasion 0.22 0.42 0.04 0.21 0.14 70.8 
Age First Child 25.78 4.40 24.62 3.02 0.05 72.2 
ck14 expression 0.78 0.75 0.58 0.72 0.04 69.4 
ck5/6 expression 1.04 0.85 0.84 0.82 0.03 72.2 
E-cad expression 1.00 0.00 0.98 0.15 0.02 73.6 
Family History Cancer 0.89 0.32 0.82 0.39 0.02 73.6 
Tobacco consumption 0.37 0.49 0.29 0.46 0.01 68.1 
Necrosis 1.26 0.90 1.40 0.75 0.01 70.8 
Pregnancies 1.93 1.27 2.11 0.98 0.01 65.3 
Age at diagnosis 58.56 14.65 60.47 13.42 0.01 65.3 
Bcl2 expression 0.63 0.74 0.73 0.81 0.01 63.9 
Age at Menarche 12.48 1.28 12.62 1.25 0.01 66.7 
Col11A1 intensity 0.89 0.85 0.96 0.82 0.00 65.3 
Ki67 expression 2.56 0.70 2.51 0.63 0.00 65.3 
Lactation 0.89 0.32 0.87 0.34 0.00 65.3 
Col11A1 expression 1.26 1.23 1.20 1.10 0.00 65.3 
Family History BEO 0.67 0.48 0.69 0.47 0.00 65.3 
E-cad truncated 0.33 0.48 0.31 0.47 0.00 65.3 
Menopause 0.96 0.19 0.96 0.21 0.00 65.3 
Col11A1 score 2.04 2.38 1.96 2.15 0.00 62.3 
Alcohol consumption 0.16 0.36 0.16 0.37 0.00 62.5 
AR expression 0.26 0.45 0.27 0.45 0.00 62.5 
p53 expression 0.70 0.47 0.71 0.46 0.00 62.53 
Oral contraceptives 0.30 0.47 0.29 0.46 0.00 61.1 
Table 7. Lymph Nodes Metastasis prediction: ranked list of prognostic variables according to their               
Fisher ratio. C1 and C2 represent the two classes of metastasis prediction, C1: positive number of 
lymph nodes, C2: no lymph nodes. 
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               Acc. 84.7 %      Acc. 83.3% 
Vascular Inv. Vascular Inv. 
Vascular 
Inv. 
Vascular invasion 
Tumor Size Tumor Size Tumor Size Tumor Size 
Perineural Inv. Perineural Inv. 
Perineural 
Inv. 
Necrosis 
Family History Cancer Necrosis Necrosis Col11A1 score 
Age at diagnosis Age at diagnosis 
Col11A1 
score 
Alcohol consumption 
Ki67 expression Ki67 expression 
AR expres-
sion 
AR expression 
Col11A1 score Col11A1 score 
p53 expres-
sion 
p53 expression 
Classifier's stability (%) 
med 83.3 80.6 77.8 77.8 
mean 80.6 80.4 79.3 79.5 
iqr 7.6 5.6 11.1 11.1 
std 5.6 7.1 7.4 7.9 
   ROC analysis (%) 
Sensitivity 78 81 78 81 
Specificity 89 84 87 84 
Table 8. Lymph nodes metastasis prediction. Other high discriminatory networks of prognostic variables with 
predictive accuracies greater than 83% ad their respective stability and ROC analysis. 
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The classifier has failed 11 samples, 5 of which were FP, 
and the other 6 were FN. The three main differences 
between the TP and TN groups are a positive Vascular 
invasion in the TP group, a higher median Tumor size of 
3 cm (versus 1.5 cm in the TN group), and a lower 
median Age at diagnosis of 55 years in the TP group 
(versus 58.50 in the TN group). The main difference 
between TP and FP groups is the Age at diagnosis that 
is much higher in the FP group (67 years old vs 55).  
Finally, figure 3 shows the correlation network for the 
Lymph Nodes prediction problem and shows the 
relationships between the most discriminatory variables.  
Discussion 
 Regarding the most discriminatory prognostic 
variables of the histological grade, it is interesting to 
note that women in the HG2 group did not have any 
Oral contraceptives intake. Population studies aimed at 
exploring associations between oral contraceptive use 
and cancer risk have shown that the risks of endometrial 
and ovarian cancer appear to be reduced with the use of 
oral contraceptives, whereas the risks of breast, cervical, 
and liver cancer appear to be increased [30]. Other 
relevant values related with patients in the HG2 group 
with respect to the HG3 group are: higher Age at 
diagnosis, Lactation habits, and number of Pregnancies 
(an average of 2.3 children for women in HG2 group vs 
1.7 in HG3 group); lower tumor size (Tsize) and Tobacco 
smoking; and lower values of the immuno-histochemical 
variables, except for the AR (Androgen Receptor) 
expression. These results provide new insights 
concerning the clinical features and habits that might 
influence a better prognosis. 
 The best prediction of the HG (disregarding the 
Nottingham grading system) was performed by a list of 
only 6 prognostic variables: Ki67 expression, Oral 
contraceptives, Col11A1 score, E-cad truncated, Tumor 
Size, and Col11A1 expression, with a very stable 
accuracy (93.8%), sensitivity (97.0%) and specificity 
(76.0%). Once again, the importance of Oral             
contraceptives in the HG prediction is highlighted. All 
these variables are crucial for breast cancer diagnosis 
and treatment [11-14, 22-29], but their combination has 
never been explored for HG assignment. The analysis of 
other equivalent networks has confirmed that Tumor 
size, Ki67 expression, Oral contraceptives, E-cad 
truncated, Col11A1 expression, p53 expression and Age 
at diagnosis are the most important prognostic variables 
in this prediction problem, and should be compulsory 
monitored to establish this important medical decision. 
The role of Ki67 expression as a prognostic marker in 
breast cancer has been also outlined by [39] in a              
large-base cohort study, concluding that it is associated 
with common histopathological parameters and as an 
additional independent prognostic factor for disease free 
and overall survivals. The relationship with the 
epithelial /mesenchymal (EMT) transition, expressed by 
the presence of ColA11, the truncated E-Cadherin and 
with the oral contraceptives intake are two main 
novelties of this analysis, since the samples with null 
Oral contraceptives intake fall in the HG2 group. 
Obviously, these values only provide general trends due 
to the possible presence of behavioral outliers.  
 The correlation network shows two main 
branches connecting Ki67 expression to Tumor size and 
AR expression, both with low correlation            
coefficients. Two branches start from AR through CK14 
expression and E-cad truncated, both weakly correlated 
to the AR node with negative coefficients. In the tumor 
size branch, all the variables seem to be related to 
habits and clinical features, Age at diagnosis,    
Menopause, Tobacco smoking, Oral contraceptives, etc. 
The low correlation among all these variables implies 
that they should be considered as independent 
prognostic factors. This graphic also confirms the strong 
correlation between the three representations of the 
Col11A1 protein. The role of the Androgen Receptor in 
breast cancer has been reviewed by [40], concluding 
that AR expression might play a role during tumor 
progression. Although histologic grading has become 
widely accepted as a powerful indicator of prognosis in 
breast cancer, no connections with other biomarkers has 
been made relevant. In our opinion this is one major 
findings of this research that will serve to improve the 
actual methods of prognosis. 
 In the case of the lymph nodes metastasis, the 
most important variables are Vascular invasion, Tumor 
size, Perineural invasion, Family history, Age at 
diagnosis, Ki67 expression and COl11A1 score, with a 
high predictive accuracy (84.7%), sensitivity (78.0%) 
and specificity (89.0%). All the samples presenting 
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Figure 3. Lymph nodes metastasis prediction. Correlation network among the most discriminatory prognostic               
variables. 
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metastasis have positive Vascular invasion (vs almost 
null in the non-metastasis group), a higher Tumor size 
mean of 2.74 cm (vs. 1.92 cm), positive Perineural 
invasion, highest age for first child (25.78 vs 24.62) and 
higher CK14 and CK5/6 expressions. The analysis of the 
equivalent networks with accuracies higher than 83% 
show high stability and a good ability for diagnostic. All 
these signatures share the Vascular invasion and Tumor 
Size as leading prognostic variables. Likewise, Col11A1 
score, Perineural invasion and/or Necrosis also appear in 
these networks. The ROC analysis established Vascular 
invasion and Tumor size as the main differences 
between the true positive (TP) and true negative (TN) 
groups, and also showed the existence of a group of 
TNBC cancers with absence of Vascular and Perineural 
invasion that presents lymph nodes metastasis (FN 
group). This kind of cancers have a lower median Tumor 
size (around 2.15 cm) than the FP group, and a median 
Col11A1 score value of 2. This knowledge is very 
important to improve the prediction of Lymph Nodes 
Metastasis at diagnostic. The correlation network shows 
one main branch starting from Vascular invasion and 
linking to Alcohol Consumption and other personal habits 
(Tobacco consumption) and clinical features (Age at 
First Child, and Tumor Size). Again, the correlations 
coefficients among these variables are very low.  
Interestingly, the immuno-histochemical variables 
appear at the base of the tree, indicating their lower 
importance in the metastasis prediction.  
 Finally, an interesting remark is that the HG and 
lymph node metastasis predictions share the Tumor size, 
Ki67 expression, and Col11A1 score as high          
discriminatory prognostic variables, confirming a certain 
link between both problems. Besides, Col11A1 score has 
a much higher predictive power than the other two 
representations of this protein. It is not surprising the 
relationships with vascular and perineural invasions, as 
well as with the tumor size or ki67 expression, but this 
analysis provides novel relationships with the expression 
of ColA11 protein and also with the patient's age.   
Conclusions 
 This study was dedicated to the HG and the 
lymph nodes metastasis prediction, crucial for 
developing more suitable treatment strategies. As 
results, we present the main clinical and pathological 
variables and their correlation networks for both 
prediction problems, via novel machine learning 
techniques. These variables are currently being used for 
prognosis and treatment in medical practice. HG was 
predicted with an accuracy of 93.8% using a list of 6 
prognostic variables with significant implications: Ki67 
expression, use of Oral contraceptives, Col11A1 
expression, Col11A1 score, E-cad truncated and Tumor 
size. The lymph nodes metastasis was predicted with an 
accuracy of almost 85% using only 6 prognostic 
variables: Vascular invasion, Tumor size, Perineural 
invasion, Age at diagnosis, Ki67 expression, and Col11A1 
score. This analysis also served to establish the median 
signatures of the groups with and without lymph node 
metastasis, and proved the existence of a kind of              
small-size tumors (around 2.15 cm) with lymph node 
metastasis but not showing vascular and perineural 
invasions and higher protein Col11A1 score. Besides, 
these signatures proved to be very stable. The additional 
information conveyed by the prognostic variables found 
in these two classification problems provides new insight 
about the genesis and progression of this disease and 
can be used in medical practice to improve decisions in 
patient diagnosis and further treatment. 
 We expect that the conclusions attained by this 
analysis will contribute to improve the understanding, 
diagnosis and prognosis of this important type of 
heterogeneous cancers. This methodology could be also 
used to predict treatment response when this kind of 
information is available, as we have shown in the case 
of Hodgkin Lymphoma [18]. 
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